STATS:
-
50.2 million (20.5%): Researchers report that 50.2 million (20.5%) U.S. adults experience chronic pain based on analysis of the new NHIS data. 1
-
Opioid Addiction: 3-million US citizens and 16 million individuals worldwide have had or currently suffer from opioid use disorder (OUD). 2
REVENUE PROJECTIONS:*
-
$50,000-$100,000 “+”/Month
FACTS/BENEFITS:
-
FDA Approved Class II Medical Device for Treatment of: Opioid Withdrawal & Chronic Pain
-
Insurance Billable Model: (Medicare, Private, Workers Comp. & PIP)
-
Implantable (NOT an Acupuncture Style Unit) which allows for complete transmission of electrical impulses. 3
-
Programmable & Modulating (Interpulse)
-
Billing: Completely In-house: Eligibility, Pre-Authorization & Billing Included
-
Training: ON Site, Procedural, Educational and Complete In-Servicing
-
Marketing and Advertising Specific To each Provider's Office
INDICATIONS:
For Patients in Need Of Safe Weaning From Opioids and/or Treatment of; Chronic Pain, Neuropathic Pain/Diabetic Neuropathy, Cervical & Lumbar Pain (Neck, Back, Spine), Failed Back Surgery, or Experiencing Opioid Withdrawal
1. April 20, 2021. Brigham and Women’s Hospital. https://www.sciencedaily.com/releases/2021/04/21
2: Mohammadreza Azadfard; Martin R. Huecker; James M. Leaming. https://www.ncbi.nlm.nih.gov/books/NBK448203
3: Data and Information provided by Black Sheep Medical